133 related articles for article (PubMed ID: 2623329)
1. Endocrine effects of adjuvant chemotherapy in premenopausal women: suggestions for the future.
Tormey DC
Recent Results Cancer Res; 1989; 115():106-12. PubMed ID: 2623329
[No Abstract] [Full Text] [Related]
2. Adjuvant chemo- and endocrine therapy alone or in combination in premenopausal patients (GABG Trial 1).
Kaufmann M; Jonat W; Abel U
Recent Results Cancer Res; 1989; 115():118-25. PubMed ID: 2696024
[No Abstract] [Full Text] [Related]
3. Scottish adjuvant breast cancer trials: results in pre-menopausal patients.
Stewart HJ
Recent Results Cancer Res; 1989; 115():126-31. PubMed ID: 2696025
[No Abstract] [Full Text] [Related]
4. Critical review of adjuvant therapy in premenopausal patients.
Mouridsen HT
Recent Results Cancer Res; 1989; 115():132-5. PubMed ID: 2623330
[No Abstract] [Full Text] [Related]
5. Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
Goldhirsch A; Gelber RD
Recent Results Cancer Res; 1989; 115():153-62. PubMed ID: 2696027
[No Abstract] [Full Text] [Related]
6. Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
Henderson IC
J Clin Oncol; 1985 Feb; 3(2):140-3. PubMed ID: 3881560
[No Abstract] [Full Text] [Related]
7. How to improve adjuvant treatment results in postmenopausal patients.
Mouridsen HT
Recent Results Cancer Res; 1989; 115():144-52. PubMed ID: 2533698
[No Abstract] [Full Text] [Related]
8. Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer.
Wallgren A; Baral E; Beling U; Carstensen J; Friberg S; Glas U; Kaigas M; Skoog L
Recent Results Cancer Res; 1984; 96():197-203. PubMed ID: 6396775
[No Abstract] [Full Text] [Related]
9. Chemo- or endocrine adjuvant therapy alone or combined in postmenopausal patients (GABG Trial 1).
Jonat W; Kaufmann M; Abel U
Recent Results Cancer Res; 1989; 115():163-9. PubMed ID: 2696028
[No Abstract] [Full Text] [Related]
10. Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
Gelber RD
Recent Results Cancer Res; 1984; 96():102-9. PubMed ID: 6396763
[No Abstract] [Full Text] [Related]
11. The Milan experience with adjuvant chemotherapy in premenopausal breast cancer.
Bonadonna G; Valagussa P; Zambetti M; Brambilla C
Recent Results Cancer Res; 1989; 115():113-7. PubMed ID: 2696023
[No Abstract] [Full Text] [Related]
12. Hormone receptors. An update and application.
Hubay CA; Arafah B; Gordon NH; Guyton SP; Crowe JP
Surg Clin North Am; 1984 Dec; 64(6):1155-72. PubMed ID: 6393400
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemo-endocrine therapy in postmenopausal women with breast cancer and axillary-node metastases.
Goldhirsch A; Castiglione M; Gelber RD
Lancet; 1990 May; 335(8697):1099-100. PubMed ID: 1970400
[No Abstract] [Full Text] [Related]
14. Relationship between estrogen receptors and CMF adjuvant chemotherapy.
Bonadonna G; Di Fronzo G; Tancini G; Brambilla C; Rossi A; Marchini S; Valagussa P
Recent Results Cancer Res; 1984; 91():205-9. PubMed ID: 6547243
[No Abstract] [Full Text] [Related]
15. Adjuvant systemic therapy in primary breast cancer.
Mouridsen HT; Palshof T
Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
[No Abstract] [Full Text] [Related]
16. Adjuvant systemic therapy for resectable breast cancer.
Bonadonna G; Valagussa P
J Clin Oncol; 1985 Feb; 3(2):259-75. PubMed ID: 3881562
[No Abstract] [Full Text] [Related]
17. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
Boccardo F; Rubagotti A; Bruzzi P; Cappellini M; Isola G; Nenci I; Piffanelli A; Scanni A; Sismondi P; Santi L
J Clin Oncol; 1990 Aug; 8(8):1310-20. PubMed ID: 2199618
[TBL] [Abstract][Full Text] [Related]
18. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M
Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial.
Tormey C
Recent Results Cancer Res; 1984; 96():155-65. PubMed ID: 6396769
[No Abstract] [Full Text] [Related]
20. Postmenopausal node-positive comparison of observation with CMFP and CMPF + tamoxifen adjuvant therapy: an Eastern Cooperative Oncology Group trial.
Tormey DC; Taylor SG; Gray R; Olson JE
Recent Results Cancer Res; 1984; 96():110-6. PubMed ID: 6396764
[No Abstract] [Full Text] [Related]
[Next] [New Search]